Navigation Links
Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy

vaccination or have recently received a vaccination. People should inform their doctor if they have a history of chronic obstructive pulmonary (lung) disease (COPD). Taking ORENCIA may cause COPD symptoms to get worse.

People who have diabetes and use a blood glucose monitor to check their sugar levels should tell their doctor. The infusion of ORENCIA contains maltose, a sugar that can give falsely high blood glucose readings with some monitors on the day the infusion is received. The doctor may recommend a different monitor.

Women who are pregnant, planning to become pregnant or are thinking about becoming pregnant should tell their doctor. It is not known if ORENCIA can harm an unborn baby. Women who are breast feeding should also inform their doctor. They will need to decide to either breast-feed or receive treatment with ORENCIA, but not both.

Important Information about Side Effects with ORENCIA

Like all medicines that affect your immune system, ORENCIA can cause serious side effects. The possible serious side effects include serious infections and allergic reactions. Also, rare cases of certain kinds of cancers have been reported.

People taking ORENCIA(R) (abatacept) are at increased risk for developing infections including pneumonia, and other infections caused by viruses, bacteria, or fungi. Individuals should call their doctor immediately if they feel sick or get any infection during treatment with ORENCIA.

Allergic reactions are usually mild or moderate, generally occur within the first 24 hours of an infusion, and include hives, swollen face, eyelids, lips, tongue, throat, or trouble breathing. There have been some serious allergic reactions reported after receiving an infusion of ORENCIA.

There have been rare cases of certain kinds of cancer. The role of ORENCIA in the development of cancer is not known.

The more common side effects with ORENCIA are headache, upper respiratory tract infection, sore
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:12/14/2009)... 14 Sword Diagnostics, Inc. is pleased ... (USPTO) has issued patent number 7,599,057 titled ... using Raman Scattering" to the company. The patent ... sensitivity. ,, "The issuance of this patent ... with our continued development and commercialization," said Dave ...
(Date:12/14/2009)... Dec. 14 Cardium Therapeutics (NYSE Amex: ... 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment ... Healing: Science and Industry Conference held December 10-13, ... The conference is attended by top industry leaders ... wound healing. Dr. Barbara K. Sosnowski, Cardium,s ...
(Date:12/14/2009)... BERKELEY HEIGHTS, N.J., Dec. 14 ... a worldwide provider of secure Health Information ... that Home Care of the Carolinas ("HCC"), ... Inc. ("AMI"), a durable medical equipment supplier, ... to streamline and standardize processes for the ...
Breaking Medicine Technology:Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 2Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 3Cardium Presents at Tenth Annual Wound Healing: Science and Industry Conference on Matrix Wound Healing Clinical Development 4Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4Injury Funds Now To the Rescue with New Lawsuit Funding Service 63006 1Injury Funds Now To the Rescue with New Lawsuit Funding Service 63006 2Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 63004 1Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 63004 2Late breaking brain and behavior research presented at ACNP annual meeting this week 63002 1Late breaking brain and behavior research presented at ACNP annual meeting this week 63002 2
... /PRNewswire-FirstCall/ -- Baxter,International Inc. today announced final Phase ... vaccine and,plans to initiate a Phase III clinical ... the study results. , The Phase I/II study ... at low doses, and induces substantial,levels of cross ...
... Demonstrates Utility in Evaluating Drug,Efficacy; Dr. H. Bryan ... ,PLEASANTON, CA, Mar 30, 2007 (MARKET WIRE via ... Dr. H. Bryan Brewer, Jr.,Chief Scientific Director of ... presentations at the recent American College of,Cardiology (ACC) ...
Other Medicine Technology:Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5
(Date:12/14/2009)... Realty Trust ("Americold") announced today that it has filed ... Securities and Exchange Commission (the "SEC") relating to a ... number of shares to be offered and the price ... The common shares to be sold in this offering ... The joint book-running managers of the offering will be ...
(Date:12/14/2009)... Aflac Incorporated announced today that it has priced ... with a coupon of 6.9%. The notes will ... yield 6.984%. The company anticipates using the proceeds ... corporate purposes. ,, Commenting on the pricing of ... Financial Officer Kriss Cloninger III commented: "This debt ...
(Date:12/14/2009)... 14 Tough Enough To Wear Pink(TM) (TETWP), ... celebrated its fifth anniversary at the signature Tough ... National Finals Rodeo (Wrangler NFR) in Las Vegas. ... rodeo cowboys, the support of the western industry ... crowd sported pink shirts, hats, bracelets and more. ...
(Date:12/14/2009)... government controlled health care, before moving to the U.S. to practice ... his new book, Health Reform: The End of the American Revolution?, ... its threat to real health care! , ... (PRWEB) ... from Minnesota, warns Americans not to sell out their liberty for ...
(Date:12/14/2009)... COLUMBUS, Ohio, Dec. 14 Skilled nursing facilities ... and services in order to deal with a 92 ... permit fee) from $6.25 to $12.01 per bed per ... that the average facility will pay an additional $17,520 ... for a total tax of $438,365 yearly. ,, Nearly ...
Breaking Medicine News(10 mins):Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3
... A study led by a team of education researchers ... Journal of the American Medical Association ( ... , Lead author David Cook, M.D., an associate professor ... Clinic, worked with researchers from Mayo and McMaster University ...
... systems, MIT study suggests , , THURSDAY, Sept. 11 (HealthDay News) ... believe your eyes. , A team of neuroscientists publishing ... said they have tricked the brain into confusing one object ... for humans to learn to recognize objects. , People never ...
... , ... Bethesda, MD (Vocus) September 11, 2008 -- ... for many teams in the spotlight have evolved from the typical ... starting running back for the Ohio State University Buckeyes, continues to ...
... Lets Nursing Home Resident Participate in Activities,and Enjoy Day ... and crafts,table at the Heartland of Columbia Nursing Home ... power wheelchair from The SCOOTER Store, Pam,Lewis, 47, is ... mobility., Heartland,s activities director, David Moreland, knew Ms. ...
... (NYSE:,NTY) (http://www.NBTY.com ), a leading global manufacturer and ... cast the,presentation by Harvey Kamil, President and Chief Financial ... in New York on Wednesday,September 17, 2008., The ... NBTY,s web site, (http://www.nbty.com ) on Wednesday, September 17, ...
... IM) announced,today the sale of their flagship product, ... The Johns Hopkins Hospital in Baltimore,Maryland., IMRISneuro ... IMRIS,one-of-a kind, movable high field MRI. The new ... operating room during brain surgery,helping to rule out ...
Other Medicine News:Health News:Internet-based instruction effective for teaching health-care professionals 2Health News:Time Teaches Brain to Recognize Objects 2Health News:Foot Injuries Plague Athletes During Fall Sports Season 2Health News:Foot Injuries Plague Athletes During Fall Sports Season 3Health News:The SCOOTER Store's Gift of a Power Wheelchair Allows Woman to Enjoy Active Life Once Again 2Health News:NBTY to Web Cast Presentation at CL King Best Ideas Conference 2
... the right viscoelastic agent for the surgeon ... extracap technique. Amvisc possesses sufficient viscosity for ... is highly cohesive so that complete removal ... easily and quickly accomplished. Amvisc is priced ...
... to provide excellent protection and ease of ... being closer to an adhesive in molecular ... CoEase to maintain viscosity at high shear ... worlds for superb performance during capsulorhexis, phaco, ...
... DUOVISC Viscoelastic System is designed to ... properties that can be used differently and ... cataract procedure. The choice of the viscoelastic ... differential ability of each to facilitate performance ...
... is used to plan precisely for the ... the surgeon can simulate the surgery using ... This enables the selection of an optimal ... and procedural costs. The surgeon can review ...
Medicine Products: